Banco de Sabadell’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $647K | Buy |
18,396
+496
| +3% | +$23.5K | 0.43% | 54 |
|
|
2025
Q4 | $911K | Sell |
17,900
-113
| -0.6% | -$5.78K | 0.59% | 47 |
|
|
2025
Q3 | $999K | Sell |
18,013
-1,719
| -9% | -$101K | 0.66% | 48 |
|
|
2025
Q2 | $1.36M | Hold |
19,732
| – | – | 0.94% | 42 |
|
|
2025
Q1 | $1.37M | Buy |
19,732
+2,105
| +12% | +$174K | 1.04% | 39 |
|
|
2024
Q4 | $1.52M | Sell |
17,627
-635
| -3% | -$68.7K | 1.19% | 40 |
|
|
2024
Q3 | $2.17M | Sell |
18,262
-2,871
| -14% | -$383K | 1.63% | 31 |
|
|
2024
Q2 | $3.02M | Buy |
21,133
+462
| +2% | +$61.2K | 2.22% | 14 |
|
|
2024
Q1 | $2.65M | Sell |
20,671
-81
| -0.4% | -$9.64K | 1.98% | 16 |
|
|
2023
Q4 | $2.15M | Sell |
20,752
-54
| -0.3% | -$5.34K | 1.63% | 25 |
|
|
2023
Q3 | $1.89M | Sell |
20,806
-750
| -3% | -$66.1K | 1.64% | 29 |
|
|
2023
Q2 | $1.74M | Sell |
21,556
-98
| -0.5% | -$8.01K | 1.4% | 37 |
|
|
2023
Q1 | $1.72M | Sell |
21,654
-2,220
| -9% | -$157K | 1.44% | 37 |
|
|
2022
Q4 | $1.62M | Buy |
23,874
+478
| +2% | +$28K | 1.36% | 39 |
|
|
2022
Q3 | $1.16M | Sell |
23,396
-3,038
| -11% | -$163K | 0.96% | 46 |
|
|
2022
Q2 | $1.47M | Sell |
26,434
-704
| -3% | -$39.1K | 1.23% | 38 |
|
|
2022
Q1 | $1.5M | Buy |
27,138
+1,952
| +8% | +$100K | 0.87% | 46 |
|
|
2021
Q4 | $1.41M | Buy |
25,186
+2,312
| +10% | +$125K | 0.79% | 49 |
|
|
2021
Q3 | $1.1M | Sell |
22,874
-1,694
| -7% | -$81.9K | 0.74% | 57 |
|
|
2021
Q2 | $1.03M | Buy |
24,568
+1,604
| +7% | +$62.2K | 0.68% | 57 |
|
|
2021
Q1 | $777K | Sell |
22,964
-97,890
| -81% | -$3.49M | 0.08% | 149 |
|
|
2020
Q4 | $4.24M | Buy |
120,854
+1,352
| +1% | +$46.7K | 0.45% | 68 |
|
|
2020
Q3 | $4.16M | Sell |
119,502
-5,022
| -4% | -$167K | 0.47% | 56 |
|
|
2020
Q2 | $4.08M | Sell |
124,524
-34,748
| -22% | -$1.11M | 0.53% | 55 |
|
|
2020
Q1 | $4.78M | Sell |
159,272
-21,162
| -12% | -$630K | 0.75% | 36 |
|
|
2019
Q4 | $5.22M | Buy |
180,434
+1,292
| +0.7% | +$35.8K | 0.69% | 35 |
|
|
2019
Q3 | $4.64M | Sell |
179,142
-42,010
| -19% | -$1.06M | 0.65% | 39 |
|
|
2019
Q2 | $5.64M | Buy |
221,152
+11,598
| +6% | +$287K | 0.65% | 42 |
|
|
2019
Q1 | $5.47M | Sell |
209,554
-5,604
| -3% | -$138K | 0.72% | 38 |
|
|
2018
Q4 | $4.94M | Buy |
215,158
+52,448
| +32% | +$1.17M | 0.6% | 43 |
|
|
2018
Q3 | $3.85M | Buy |
162,710
+33,928
| +26% | +$828K | 0.42% | 55 |
|
|
2018
Q2 | $2.95M | Buy |
128,782
+4,400
| +4% | +$105K | 0.38% | 65 |
|
|
2018
Q1 | $3.06M | Buy |
124,382
+90,192
| +264% | +$2.37M | 0.37% | 61 |
|
|
2017
Q4 | $917K | Buy |
+34,190
| New | +$869K | 0.12% | 171 |
|
Other funds holding NVO
DAM
F
Banco de Sabadell's NVO Position: Q1 2026 in Review
Banco de Sabadell increased its Novo Nordisk (NVO) stake by 2.8% in Q1 2026, buying an estimated $23.5K and bringing the position to 18,396 shares worth $647K. The position accounts for 0.43% of the portfolio, ranked #54.
Banco de Sabadell first reported a position in NVO in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.64M in Q2 2019. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Banco de Sabadell held 18,396 shares of Novo Nordisk worth $647K as of Q1 2026.
- Banco de Sabadell bought 496 Novo Nordisk shares in Q1 2026, an estimated $23.5K.
- Novo Nordisk made up 0.43% of Banco de Sabadell's portfolio in Q1 2026, its #54 holding.
- Banco de Sabadell first reported a position in Novo Nordisk in Q4 2017 and has held it in 34 quarters since.
- Banco de Sabadell's Novo Nordisk position peaked at $5.64M in Q2 2019.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Banco de Sabadell's 13F filing for Q1 2026, filed 8 May 2026.